Efficacy and Safety of Acupuncture for Dizziness and Vertigo in Emergency Department: a Clinical Control Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-28

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dizziness and vertigo account for roughly 4% of chief symptoms in the emergency department (ED). Pharmacological therapy is often solicited for these symptoms, such as vestibular suppressants, anti-emetics and benzodiazepines. However, every medication is accompanied with unavoidable side-effects. To the best of the investigators knowledge, no papers surveyed assess the feasibility of applying acupuncture as an emergent intervention means to the treatment of dizziness and vertigo. The investigators study targeted on filling in this gap by performing a clinical control trial to evaluate the efficacy and safety of traditional Chinese medicine - acupuncture - in treating patients with dizziness and vertigo in ED.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acupuncture for Pain Control in the Emergency Department

NCT02013908

Neck Pain Ankle Injuries Headache Disorders, Primary

TERMINATED NA

Use of ACUPUNCTURE in Emergency Departement

NCT01622959

Age ≥18 Years Presigned Consentement to Participate in the Study

COMPLETED NA

Acupuncture in the Emergency Department

NCT02888340

Pain

COMPLETED NA

Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement

NCT02383004

Delirium Psychomotor Agitation

COMPLETED NA

Skin and Acupuncture Needle Vibration Behaviors Through Observation

NCT02442076

Skin Vibration Acupuncture

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dizziness Vertigo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Efficacy and safety of acupuncture for dizziness and vertigo

To evaluate the efficacy and safety of acupuncture in treating patients with dizziness and vertigo in ED.

Group Type EXPERIMENTAL

acupuncture

Intervention Type PROCEDURE

Experiment group received acupuncture at Zusanli (ST36) and Neiguan (PC6) acupuncture points

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

acupuncture

Experiment group received acupuncture at Zusanli (ST36) and Neiguan (PC6) acupuncture points

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Visit emergency department and stay in observation unit.
* Consult otolaryngologist and neurologist to rule in dizziness and giddiness, auditory vertigo, vertebrobasilar artery syndrome, and peripheral vestibular disorders - Ménière's disease, benign paroxymal peripheral vertigo, and vestibular neuritis.

Exclusion Criteria

1. Serious comorbid conditions (for example, life-threatening condition or progressive central disorder).
2. Patients who cannot communicate reliably with the investigator or who are not likely to obey the instructions of the trial.

Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No